PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
6.98%
Revenue growth 1.25-1.5x QCOM's 4.68%. Bruce Berkowitz would check if differentiation or pricing power justifies outperformance.
11.21%
Gross profit growth above 1.5x QCOM's 3.15%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
25.22%
EBIT growth above 1.5x QCOM's 4.55%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
25.22%
Operating income growth above 1.5x QCOM's 4.55%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
27.21%
Net income growth above 1.5x QCOM's 9.92%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
30.95%
EPS growth above 1.5x QCOM's 9.09%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
28.57%
Diluted EPS growth above 1.5x QCOM's 9.30%. David Dodd would see if there's a robust moat protecting these shareholder gains.
-1.39%
Share reduction while QCOM is at 0.66%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-1.43%
Reduced diluted shares while QCOM is at 0.65%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
0.53%
Dividend growth of 0.53% while QCOM is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
70.49%
Positive OCF growth while QCOM is negative. John Neff would see this as a clear operational advantage vs. the competitor.
90.47%
Positive FCF growth while QCOM is negative. John Neff would see a strong competitive edge in net cash generation.
59.81%
Positive 10Y revenue/share CAGR while QCOM is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
96.53%
5Y revenue/share CAGR at 50-75% of QCOM's 179.24%. Martin Whitman would worry about a lagging mid-term growth trajectory.
37.60%
3Y revenue/share CAGR at 50-75% of QCOM's 68.43%. Martin Whitman would question if the firm lags behind competitor innovations.
205.28%
10Y OCF/share CAGR in line with QCOM's 223.51%. Walter Schloss would see both as similarly efficient over the decade.
226.83%
Below 50% of QCOM's 1205.22%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
98.43%
3Y OCF/share CAGR at 75-90% of QCOM's 117.00%. Bill Ackman would press for improvements in margin or overhead to catch up.
-50.56%
Negative 10Y net income/share CAGR while QCOM is at 93.28%. Joel Greenblatt sees a major red flag in long-term profit erosion.
397.85%
Below 50% of QCOM's 5466.57%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
68.28%
3Y net income/share CAGR 1.25-1.5x QCOM's 59.32%. Bruce Berkowitz might see new markets, M&A, or better cost discipline driving the difference.
92.20%
10Y equity/share CAGR above 1.5x QCOM's 43.75%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
21.10%
Below 50% of QCOM's 181.22%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
5.44%
Below 50% of QCOM's 69.25%. Michael Burry suspects a serious short-term disadvantage in building book value.
288.56%
Dividend/share CAGR of 288.56% while QCOM is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
278.60%
Dividend/share CAGR of 278.60% while QCOM is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
286.61%
3Y dividend/share CAGR above 1.5x QCOM's 180.08%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
6.64%
AR growth well above QCOM's 7.00%. Michael Burry fears inflated revenue or higher default risk in the near future.
1.83%
Inventory shrinking or stable vs. QCOM's 14.12%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
-2.11%
Negative asset growth while QCOM invests at 6.91%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-1.74%
We have a declining book value while QCOM shows 5.30%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
-1.63%
Our R&D shrinks while QCOM invests at 0.00%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
1.18%
SG&A declining or stable vs. QCOM's 4.16%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.